相关实验视频
Updated: Sep 19, 2025

Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
专家观点:卡斯特曼病的诊断和治疗
Luke Y C Chen1, Lu Zhang2, David C Fajgenbaum3
1Division of Hematology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada, and Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
卡斯特曼病 (CD) 是一种罕见的淋巴增殖性疾病. 异形多中心卡斯特曼病 (iMCD) 呈现出多种症状,构成诊断挑战,但西尔图西马布是一种有前途的第一线治疗.
科学领域:
- 类风湿病学 类风湿病学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 卡斯特曼病 (CD) 是一种异质的淋巴增殖性疾病.
- 单中心性CD (UCD) 和多中心性CD (MCD) 呈现出不同的临床挑战.
- MCD的亚型包括与血细胞瘤相关的,HHV-8阳性和异常性MCD (iMCD).
研究的目的:
- 阐明卡斯特曼病的诊断复杂性,特别是IMCD.
- 概述iMCD的异质症状和亚型.
- 审查IMCD目前和新兴的治疗策略.
主要方法:
- 对CD亚型的临床表现和诊断标准的审查.
- 分析与其他免疫媒介疾病重叠的症状.
- 综合治疗方式,包括免疫调节剂,抗淋巴瘤和抗髓瘤疗法.
主要成果:
- 由于模仿其他疾病的各种症状,iMCD带来了诊断挑战.
- 三种iMCD亚型 (TAFRO,IPL,NOS) 呈现出不同的临床和实验室特征.
- 作为IL-6抗剂的西尔图西马布是所有iMCD亚型的推第一线治疗方法.
结论:
- 准确的IMCD诊断需要整合组织学,临床和实验室发现.
- 早期识别和适当的治疗对于管理iMCD至关重要.
- 对于耐火性iMCD病例,建议专门的中心和治疗指南.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Chronic Pancreatitis II: Collaborative Care
Assessment:

